Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for bimekizumab (Bimzelx) for active psoriatic arthritis (PsA) in adults. Bimekizumab can be used alone or in combination with a conventional non-biologic disease-modifying antirheumatic drug (cDMARD) (e.g., methotrexate).